VUB research on immunotherapy for multiple myeloma establishes baseline for improved long-term success
Dr. Heleen Hanssens from the Molecular Imaging and Therapy (MITH) Research Group at Vrije Universiteit Brussel (VUB) has conducted research on the application of CAR T-cell therapy in multiple myeloma, a form of bone marrow cancer that remains considered incurable.
Dr. Hanssens explains: "CAR T-cell therapy is an innovative treatment that harnesses the patient’s own immune system to attack cancer. T-cells, a type of white blood cell, are extracted from the patient’s blood and genetically modified. ...
